Silver Investment Partners, a provider of investment services, completed the acquisition of a majority stake in Lucien Ortscheit, a pharmaceuticals company. Financial terms were not disclosed. The former owners, the Kloos family, will retain a minority stake in the company. Mr. Kloos will continue to act as managing director and will be responsible for the operative business in the medium term. SIP supports Lucien Ortscheit's sustainable growth strategy. In order to further develop the company, growth opportunities such as international expansion, expansion of the product range and add-on acquisitions in a domestic and international attractive niche market shall be used.